Understanding Allergic Contact Dermatitis from Medical Adhesives and Continuous Glucose Monitors
Allergic contact dermatitis from medical adhesives is an increasingly recognised skin reaction among people who use wearable health devices, particularly continuous glucose monitors (CGMs). As CGM technology becomes more widely adopted across the UK — including in London — understanding the skin immune responses these devices can trigger is an important part of informed self-care and health screening.
This educational guide explains what allergic contact dermatitis is, how it relates to medical adhesives and CGMs, what skin patch testing can reveal, and how to approach suspected reactions in a clinically appropriate way.
What Is Allergic Contact Dermatitis? (Definition)
Allergic contact dermatitis (ACD) is a delayed hypersensitivity skin reaction triggered when the immune system identifies a substance — known as an allergen — as harmful. Unlike irritant reactions, ACD involves a T-cell mediated immune response and typically develops 24–72 hours after contact with the sensitising substance. Symptoms may include redness, itching, blistering, and localised swelling at the site of contact.
How Do Medical Adhesives Cause Skin Reactions?
Medical-grade adhesives are used across a wide range of wearable devices — from wound dressings and electrodes to CGMs and continuous cardiac monitors. These adhesives contain multiple chemical components, any one of which may become a sensitiser in susceptible individuals.
Common Sensitising Agents Found in Medical Adhesives
- Acrylates and methacrylates — widely used in pressure-sensitive adhesive formulations
- Colophony (rosin) — a natural resin derived from pine trees used in some adhesive backings
- Epoxy resins — found in some patch adhesive layers
- Thiourea compounds — used in certain foam backings
- Fragrances and preservatives — including methylisothiazolinone (MI) and formaldehyde-releasers
When skin is exposed to these substances repeatedly over days or weeks, the immune system can become sensitised. Subsequent exposures — even to trace amounts — can then trigger a localised allergic response.
Practical Insight: Not everyone who uses medical adhesives will develop ACD. Many users tolerate adhesive-based devices without difficulty. However, individuals with a history of skin sensitivity, eczema, or known chemical allergies may be at greater risk.
Continuous Glucose Monitors and Skin Reactions: What the Evidence Suggests
CGMs have transformed blood glucose management for people living with diabetes across the UK. Devices such as the Libre and Dexcom systems use an adhesive patch to hold a sensor beneath or near the skin's surface for days at a time. Prolonged skin contact with these adhesive components increases the potential for sensitisation.
Reported Skin Reactions in CGM Users
| Reaction Type | Likely Cause | Timing After Application | Typical Appearance |
|---|---|---|---|
| Irritant contact dermatitis | Occlusion, friction, or moisture | Within hours | Redness, mild scaling |
| Allergic contact dermatitis | Acrylate or adhesive allergen | 24–96 hours | Blistering, intense itch, clear margins |
| Pressure urticaria | Mechanical pressure from device | During or immediately after wear | Raised wheals, transient redness |
| Folliculitis | Sweat and occlusion | After several days | Papules, pustules around hair follicles |
Practical Insight: Allergic contact dermatitis characteristically follows the exact outline of the adhesive patch — a clinical sign sometimes described as a "geometric rash." This pattern can help distinguish ACD from other skin conditions.
Published dermatological literature increasingly identifies acrylates — particularly isobornyl acrylate (IBOA) — as a key sensitiser in several CGM brands. This has prompted growing clinical interest in patch testing for CGM users experiencing persistent or worsening skin reactions.
Who Should Consider Skin Allergy Testing?
Skin allergy assessment, including patch testing, may be worth exploring for individuals who:
- Experience repeated skin reactions at CGM or adhesive device sites
- Notice that reactions are worsening with each sensor change
- Have a personal or family history of eczema, allergic rhinitis, or known contact allergies
- Have tried barrier creams or device rotation without resolution of symptoms
- Are uncertain whether their skin reaction is allergic or irritant in nature
People living with diabetes in London and across the UK who rely on CGMs for daily glucose monitoring may find that understanding their skin allergen profile helps them make more informed decisions about device management in discussion with appropriate healthcare professionals.
Explore our allergy testing services for information on what assessment options are available through our nurse-led clinic.
What Does Patch Testing Involve?
Patch testing is the clinical gold standard for identifying delayed hypersensitivity reactions such as allergic contact dermatitis. It involves applying small amounts of standardised allergens to the upper back under occlusive discs, which remain in place for 48 hours. Readings are taken at 48 and 96 hours (sometimes also at 7 days) to assess for delayed reactions.
What Patch Testing Can Reveal
- Specific chemical sensitisers responsible for a skin reaction
- Whether a reaction is truly allergic or irritant
- Cross-reactivity between related substances (e.g., different acrylates)
- A clearer understanding of which materials to avoid going forward
Our clinic provides allergy testing and reporting only. We do not offer prescriptions, treatment, or clinical management — but our detailed reports can support conversations with appropriate healthcare professionals.
You may find our allergy testing information helpful in understanding what the process involves.
Understanding Your Patch Test Results
A positive patch test result indicates that the immune system has produced a measurable response to a particular allergen. This may suggest that the substance in question is contributing to a contact dermatitis reaction. Results are graded on a standardised scale:
| Grade | Symbol | Meaning |
|---|---|---|
| Negative | – | No reaction observed |
| Doubtful | +/– | Faint, non-specific response |
| Weak positive | + | Erythema and papules |
| Strong positive | ++ | Erythema, papules, and vesicles |
| Extreme positive | +++ | Blistering, spreading reaction |
| Irritant reaction | IR | Localised mechanical, not immunological |
A negative result does not rule out an irritant reaction, and results must always be interpreted in the context of the individual's clinical history.
Practical Insight: Understanding which specific allergen is responsible — whether an acrylate, a rosin derivative, or another compound — can be clinically meaningful when selecting device alternatives or protective approaches to discuss with a healthcare professional.
How Often Should Testing Be Considered?
There is no fixed universal frequency for patch testing. However, repeat testing may be appropriate if:
- New materials or adhesive products have been introduced since previous testing
- Skin reactions are recurring or evolving despite known avoidance measures
- A new wearable device has been adopted
Allergy sensitisation can develop over time, meaning an individual who previously tolerated a substance may develop a reaction after repeated exposures. If in doubt, seeking updated allergy information is a reasonable step.
Visit our contact us page to find out more about booking an appointment at our London allergy clinic.
London and the UK Context
Across London and the wider UK, the adoption of CGM technology has grown significantly since the NICE 2022 guidance on continuous glucose monitoring for people with Type 1 diabetes. With growing numbers of individuals wearing these devices around the clock, dermatological reactions are increasingly being reported in primary care settings.
The UK's NHS provides excellent clinical pathways for diabetes management. However, specialist allergy patch testing — particularly for device-related contact allergens such as acrylates — may not always be immediately accessible through NHS routes. Private nurse-led allergy clinics in London can offer an accessible, evidence-informed alternative for individuals seeking a clearer understanding of their skin immune response.
Read more about skin and contact allergy assessment available through our clinic.
Frequently Asked Questions
1. What is allergic contact dermatitis from medical adhesives?
Allergic contact dermatitis from medical adhesives is a delayed immune-mediated skin reaction caused by sensitisation to chemical components within adhesive patches. It typically appears 24–96 hours after contact and is characterised by itching, redness, and sometimes blistering at the adhesive site, closely mirroring its shape.
2. Can CGMs cause allergic contact dermatitis?
Yes, continuous glucose monitors can cause allergic contact dermatitis in some users. The adhesive patches used to secure CGM sensors contain chemicals — particularly acrylates such as isobornyl acrylate — that may trigger a sensitised immune response in susceptible individuals after repeated or prolonged exposure.
3. How do I know if my CGM reaction is allergic or just irritation?
Allergic contact dermatitis tends to produce intense itching, blistering, and a well-defined rash that exactly follows the adhesive outline, typically appearing 24–72 hours after application. Irritant reactions are usually milder, appear sooner, and may fade quickly. Patch testing can help differentiate between the two.
4. What allergens are commonly found in CGM adhesives?
Common sensitisers in CGM adhesives include isobornyl acrylate (IBOA), other acrylates and methacrylates, colophony, epoxy resins, and preservatives. Specific allergen profiles vary by device brand and model, which is why patch testing against a broad standard series — including an acrylate series — may be informative.
5. Is patch testing available privately in London?
Yes. Patch testing is available through private allergy clinics in London, including our nurse-led clinic. We offer allergy testing and structured reporting to help individuals understand their skin allergen profile. We do not offer treatment or prescriptions — our role is to test and report.
6. How long does patch testing take?
The patch testing process typically takes place over several days. Allergen patches are applied to the upper back and remain in place for 48 hours. Readings are then taken at 48 hours and again at 96 hours or beyond to capture delayed reactions. Some protocols also include a 7-day reading.
7. Can I still use a CGM if I have allergic contact dermatitis?
This is a question best discussed with an appropriate healthcare professional who can consider your individual circumstances. Understanding which specific allergen is responsible — through patch testing — may help inform practical options. Our clinic can provide test results and reports to support those conversations.
8. Does allergic contact dermatitis from adhesives go away on its own?
Allergic contact dermatitis may improve once the causative substance is no longer in contact with the skin. However, because it is an immune-mediated response, the sensitisation itself typically persists. Future exposures to the same allergen are likely to trigger a reaction. This is why identifying the specific allergen can be useful.
9. Are some people more likely to develop acrylate allergy from CGMs?
Individuals with a pre-existing history of eczema, atopic dermatitis, or other contact allergies may have a slightly higher likelihood of developing sensitisation. However, acrylate allergy from CGMs can develop in individuals with no prior history of skin conditions, particularly with prolonged and repeated device use.
10. What should I do if I suspect I have allergic contact dermatitis from my device?
If you suspect an allergic skin reaction from a medical device, it is advisable to seek appropriate medical advice. If symptoms are severe — such as significant swelling, blistering, or spreading rash — seek urgent medical care. For individuals wishing to understand their allergen profile, patch testing through an allergy clinic may provide helpful information.
EEAT Authority Note
This article has been written in line with UK medical editorial standards and reflects current evidence-based understanding of allergic contact dermatitis in the context of medical adhesive and CGM use. Information is drawn from published dermatological literature and established allergy clinical practice. All content is intended for educational purposes and does not represent a clinical assessment of any individual's condition.
Our clinic is nurse-led and provides allergy testing and structured health reporting only. We do not offer prescriptions, specialist diagnoses, GP services, treatment plans, or medical interventions of any kind.
Ready to Learn More About Your Skin Health?
If you have been experiencing unexplained skin reactions to wearable devices or medical adhesives, understanding your allergen profile may be a helpful step in your health journey. Our nurse-led allergy clinic in London offers structured, accessible testing and clear reporting to help you make informed decisions alongside your healthcare team.
Explore our allergy testing services at Allergy Clinic — no pressure, no urgency, just informed support.
Disclaimer: This article is intended for educational and informational purposes only. It does not constitute medical advice, a clinical assessment, or a diagnosis of any individual's health condition. The content presented here should not be used as a substitute for professional medical advice, examination, or guidance from a qualified healthcare professional. If you are experiencing skin reactions, health concerns, or have questions about your test results, please consult an appropriate healthcare professional. If symptoms are severe or rapidly worsening, seek urgent medical care. This clinic provides testing and reporting services only and does not offer treatment, prescriptions, or specialist medical services. No outcomes are guaranteed. All information is provided in good faith for general educational awareness in line with GMC, CQC, and ASA communication standards.
